Table 1.
Characteristics of the study population.
| Mean | SD | n | |
|---|---|---|---|
| Age (Year) | 68 | 9.5 | 1914 |
| Disease Duration (Years) | 3.0 | 2.1 | 1887 |
| LADS-Anxiety | 4.1 | 3.6 | 1737 |
| LADS-Depression | 4.5 | 3.2 | 1729 |
| MDS-UPDRS-III | 27 | 13.6 | 1657 |
| MDS-UPDRS-III (OFF) | 33.5 | 15.5 | 495 |
| MDS-UPDRS-IV | 1.2 | 2.4 | 1685 |
| SCOPA-AUT | 12.5 | 7.2 | 823 |
| MoCA | 25.1 | 3.6 | 1706 |
| SFMPQ | 6.8 | 6.6 | 1944 |
| EQ-5D Index | 0.71 | 0.24 | 1751 |
SD, standard deviation; LADS-Anxiety, Leeds Anxiety and Depression Scale-Anxiety; LADS-Depression, Leeds Anxiety and Depression Scale-Depression; MDS-UPDRS-III, Unified Parkinson's disease Rating Scale Part III (motor examination); MDS-UPDRS-IV, Unified Parkinson's disease Rating Scale Part IV (motor complications); SCOPA-AUT, the Scales for Outcomes in Parkinson's disease – Autonomic Symptoms. MoCA, Montreal Cognitive Assessment; SFMPQ, Short Form McGill Pain Questionnaire; EQ-5D Index, Quality of Life Scale.